Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114647

A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.

N Talal, R F Garry, P H Schur, S Alexander, M J Dauphinée, I H Livas, A Ballester, M Takei, and H Dang

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Talal, N. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Garry, R. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Schur, P. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Alexander, S. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Dauphinée, M. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Livas, I. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Ballester, A. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Takei, M. in: PubMed | Google Scholar

Clinical Immunology Section, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.

Find articles by Dang, H. in: PubMed | Google Scholar

Published June 1, 1990 - More info

Published in Volume 85, Issue 6 on June 1, 1990
J Clin Invest. 1990;85(6):1866–1871. https://doi.org/10.1172/JCI114647.
© 1990 The American Society for Clinical Investigation
Published June 1, 1990 - Version history
View PDF
Abstract

22 of 61 systemic lupus erythematosus (SLE) patients produced antibodies to the p24 gag protein of HIV-1 demonstrated by Western blotting. 20 of these 22 patients (91%) also express the 4B4 idiotype (Id 4B4) previously identified on a human anti-Sm monoclonal antibody called 4B4. This represents an enrichment for this Id (seen in only 52% of SLE patients generally). Eight of these 22 SLE patients also have anti-Sm antibody activity. Sm partially inhibits the antibody binding of p24 gag suggesting immunologic cross-reactivity between the retroviral antigen p24 gag and the autoantigen Sm. Anti-Id 4B4 also inhibits p24 gag antibody binding by as much as 40%. Finally the monoclonal antibody 4B4 showed cross-reactivity to Sm and p24 gag. The following points emerge from our studies: (a) SLE patients make antibodies to p24 gag of HIV-1, (b) there is a relationship between immunity to p24 gag and a conserved idiotype, and (c) anti-Sm antibodies can cross-react with p24 gag.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1866
page 1866
icon of scanned page 1867
page 1867
icon of scanned page 1868
page 1868
icon of scanned page 1869
page 1869
icon of scanned page 1870
page 1870
icon of scanned page 1871
page 1871
Version history
  • Version 1 (June 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts